Kathryn (Kate) Haviland

Vice President Rare Diseases and Oncology Program Leadership

Boston, MA

Message for Free

Show Contact Info

Work:

Employment History of Kathryn (Kate) Haviland

Idera Pharmaceuticals

Vice President Rare Diseases and Oncology Program Leadership

Sarepta Therapeutics

Head of Commercial Development

Blueprint Medicines

Chief Business Officer

PTC Therapeutics, Inc.

Executive Director, Commercial Development

Sanofi

Principal, Corporate Development

PA Consulting Group

Consultant

Fulcrum Therapeutics

Chairman Of The Board Of Directors

Schools:

Schools Attended by Kathryn (Kate) Haviland

Harvard Business School

Wesleyan University

Others that have worked at the same companies

Michael Lin

Managing Director at mba2005.hbs.edu

Chao Zhang

Investment Management at mba2005.hbs.edu

Robert Woolley

Group Vice President at mba2005.hbs.edu

Kylie O'Keefe

Chief Commercial Officer (CCO) at ptcbio.com

Emily Hill

CFO at ptcbio.com

Paul Martin

Vice President, Intellectual Property and Deputy General Counsel at ptcbio.com

Vin Milano

Chief Executive Officer at iderapharma.com

Alberto Visintin

Sr. Director - Head of Immunology and Preclinical Research at iderapharma.com

Lou Brenner

President and Chief Executive Officer at iderapharma.com